Molecular genetic and immunohistochemical analysis of the tumor suppressor genes Rb and p53 in palmar and aggressive fibromatosis

被引:26
作者
Muller, E
Castagnaro, M
Yandel, DW
Wolfe, HJ
Alman, BA
机构
[1] TUFTS UNIV NEW ENGLAND MED CTR,DEPT PATHOL,BOSTON,MA 02111
[2] TUFTS UNIV NEW ENGLAND MED CTR,DEPT ORTHOPAED,BOSTON,MA 02111
[3] TUFTS UNIV,SCH MED,BOSTON,MA 02111
[4] UNIV VERMONT,DEPT PATHOL,BURLINGTON,VT 05405
关键词
aggressive fibromatosis; palmar fibromatosis; Rb; p53; PCR; SSCP; immunohistochemistry;
D O I
10.1097/00019606-199609000-00008
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
This pilot project analyzed the tumor suppressor genes p53 and Rb in 13 cases of aggressive fibromatoses and six cases of palmar fibromatoses (Dupuytren contracture), Immunohistochemistry, reverse transcription polymerase chain reaction, polymerase chain reaction followed by single-strand confirmation polymorphism analysis, and Southern blot to detect gene rearrangements were used. No abnormalities were detected in p53, The aggressive fibromatoses demonstrated a lack of Rb immunohistochemical staining acid decreased mRNA for Rb. No structural mutation in the coding sequence of the Rb gene was detected. The decreased lever of Rb gene expression, de spite a normal coding sequence, may indicate increased proliferation and may suggest potential treatment schemes.
引用
收藏
页码:194 / 200
页数:7
相关论文
共 36 条
[1]   PLATELET-DERIVED GROWTH-FACTOR IN FIBROUS MUSCULOSKELETAL DISORDERS - A STUDY OF PATHOLOGICAL TISSUE-SECTIONS AND IN-VITRO PRIMARY-CELL CULTURES [J].
ALMAN, BA ;
NABER, SP ;
TEREK, RM ;
JIRANEK, WA ;
GOLDBERG, MJ ;
WOLFE, HJ .
JOURNAL OF ORTHOPAEDIC RESEARCH, 1995, 13 (01) :67-77
[2]  
ALMAN BA, 1992, J PEDIATR ORTHOPED, V12, P10
[3]   SOMATOSTATIN RECEPTOR-POSITIVE PRIMARY BREAST-TUMORS - GENETIC, PATIENT AND TUMOR CHARACTERISTICS [J].
BOOTSMA, AH ;
VANEIJCK, C ;
SCHOUTEN, KK ;
REUBI, JC ;
WASER, B ;
FOEKENS, JA ;
VANPEL, R ;
ZWARTHOFF, EC ;
LAMBERTS, SWJ ;
DEKLEIN, A .
INTERNATIONAL JOURNAL OF CANCER, 1993, 54 (03) :357-362
[4]  
BOWMAN F, 1993, DIAGN MOL PATHOL, V2, P14
[5]  
CAIRNS P, 1991, ONCOGENE, V6, P2305
[6]   ALTERED EXPRESSION OF THE RETINOBLASTOMA GENE-PRODUCT IN HUMAN SARCOMAS [J].
CANCE, WG ;
BRENNAN, MF ;
DUDAS, ME ;
HUANG, CM ;
CORDONCARDO, C .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (21) :1457-1462
[7]  
CASTAGNARO M, 1993, VERH DEUT G, V77, P119
[8]   P53 EXPRESSION IN BREAST-CANCER [J].
CATTORETTI, G ;
RILKE, F ;
ANDREOLA, S ;
DAMATO, L ;
DELIA, D .
INTERNATIONAL JOURNAL OF CANCER, 1988, 41 (02) :178-183
[9]   CYTOSTATIC GENE-THERAPY FOR VASCULAR PROLIFERATIVE DISORDERS WITH A CONSTITUTIVELY ACTIVE FORM OF THE RETINOBLASTOMA GENE-PRODUCT [J].
CHANG, MW ;
BARR, E ;
SELTZER, J ;
JIANG, YQ ;
NABEL, GJ ;
NABEL, EG ;
PARMACEK, MS ;
LEIDEN, JM .
SCIENCE, 1995, 267 (5197) :518-522
[10]   ISOLATION OF BIOLOGICALLY-ACTIVE RIBONUCLEIC-ACID FROM SOURCES ENRICHED IN RIBONUCLEASE [J].
CHIRGWIN, JM ;
PRZYBYLA, AE ;
MACDONALD, RJ ;
RUTTER, WJ .
BIOCHEMISTRY, 1979, 18 (24) :5294-5299